Kura Oncology KURA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$294.57M-5.7% | -$278.67M-28.5% | -$216.88M-10.0% | -$197.17M-8.4% | -$181.89M-4.5% | ||
| $1.15M+11.0% | $1.03M+23.9% | $833K-5.0% | $877K+2.6% | $855K+0.8% | ||
| $37.68M+1.5% | $37.11M+7.9% | $34.39M+8.3% | $31.75M-4.5% | $33.23M-2.0% | ||
| —— | —— | $87.8M-29.8% | $124.99M+12.4% | $111.23M-17.2% | ||
| $6.47M-2.5% | $6.64M+41.6% | $4.69M+121% | $2.12M+212% | $680K+44.1% | ||
| —— | —— | —— | —— | —— | ||
| $1.72M-4.1% | $1.79M+22.5% | $1.46M-60.1% | $3.67M-40.8% | $6.19M-96.0% | ||
| —— | —— | —— | —— | $9.76M-94.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Kura Oncology generate?
- Kura Oncology (KURA) generated -$267.2M in operating cash flow over the trailing twelve months.
- What is Kura Oncology's free cash flow?
- After $6.5M of capital expenditures, Kura Oncology's free cash flow was -$271.6M over the trailing twelve months, down 302.9% year over year.
- Where does Kura Oncology's cash flow data come from?
- Every line is extracted from Kura Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
